Replimune Group, Inc. (REPL) earnings
REPL earnings moved a median of +1.17% by the close. Quarterly and annual REPL reports and results, each read against the price at its own news timestamp. Back to the REPL overview →
11 measured REPL earnings events.
Where these REPL earnings landedvs 10 measured REPL earnings reactions
| Middle 50% of REPL earnings reactions | -0.70% to +4.98% |
|---|---|
| Median reaction (to close) | +1.17% |
| Measured reactions | 10 |
Point-in-time · zero look-ahead
Half of the 10 REPL earnings events with a measured close landed between -0.70% and +4.98%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q/A Replimune Group, Inc. For: Sep 30 | SEC filing · Form 10-Q | — | — | |
| Form 10-Q Replimune Group, Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.93% | +23.92% | |
| Replimune Reports Fiscal Second Quarter 2027 Financial Results and Provides Corporate Update | Press release | -1.93% | +23.92% | |
| Replimune to Report the Fiscal Second Quarter 2027 Financial Results and Provide Corporate Update on October 28, 2026 | Press release | -0.94% | +2.48% | |
| Form 10-Q Replimune Group, Inc. For: Jun 30 | SEC filing · Form 10-Q | -1.95% | -0.14% | |
| Replimune Reports Fiscal First Quarter 2027 Financial Results and Provides Corporate Update | Press release | -0.59% | -1.45% | |
| Form 10-K Replimune Group, Inc. For: Mar 31 | SEC filing · Form 10-K | -2.13% | -2.44% | |
| Form 10-Q Replimune Group, Inc. For: Dec 31 | SEC filing · Form 10-Q | +0.07% | +4.98% | |
| Replimune Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update | Press release | +0.07% | +4.98% | |
| Form 10-Q Replimune Group, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.47% | -0.70% | |
| Replimune Reports Fiscal Second Quarter 2026 Financial Results and Provides Corporate Update | Press release | -0.47% | -0.70% |
Keep exploring
More REPL: analyst actions → · SEC filings → · REPL overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) | 1,452 | +0.01% | 51% |
| GENMARK DIAGNOSTICS (GNMK) | 1,451 | +0.06% | 51% |
| Altimmune, Inc. (ALT) | 1,424 | 0.00% | 48% |
| PerkinElmer, Inc. (PKI) | 1,409 | +0.11% | 56% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.